Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates
Human Gene Therapy Clinical Development · 2014
DOI: 10.1089/hum.2013.201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Gene Therapy Clinical Development, 2014. Verfasst von Justin Charles Roth und 13 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Roth, J. C., Cassady, K. A., Cody, J. J., Parker, J. N., Price, K. H., Coleman, J. M., Peggins, J. O., Noker, P. E., Powers, N., Grimes, S., Carroll, S. L., Gillespie, G. Y., Whitley, R., & Markert, J. (2014). Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates. Human Gene Therapy Clinical Development. https://doi.org/10.1089/hum.2013.201
Vancouver
Roth JC, Cassady KA, Cody JJ, Parker JN, Price KH, Coleman JM, et al. Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates. Human Gene Therapy Clinical Development. 2014. doi:10.1089/hum.2013.201
BibTeX
@article{Roth2014,
author = {Roth, Justin Charles and Cassady, Kevin A and Cody, James J and Parker, Jackie N and Price, Kathleen H and Coleman, Jennifer M and Peggins, James O and Noker, Patricia E and Powers, Nicholas and Grimes, Sheila and Carroll, Steven L and Gillespie, G. Yancey and Whitley, Richard and Markert, James},
title = {Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates},
journal = {Human Gene Therapy Clinical Development},
year = {2014},
doi = {10.1089/hum.2013.201}
}
EUVIMED